Texas Medical Center announced the latest cohorts from two health tech accelerators.
Texas Medical Center Innovation has named eight of his companies as accelerators for his HealthTech cohort for Spring 2023. TMCi also announced that 21 participants will join his Accelerator for Cancer Therapeutics 2023 cohort. Both programs connect entrepreneurs and innovators with experts at his TMC site to solve unmet clinical needs and help businesses reach their next milestone.
Emily Reiser, Associate Director of TMC Innovation, said in a press release: “Our 2023 cohort members are addressing some of the most important issues facing healthcare today.
“We are delighted to welcome a new group of researchers and companies to her TMC Innovation Factory and to work with new cohort members and partners across her center at Texas Medical,” she continues.
Here’s what to expect from these cohorts of her two programs in 2023:
TMCi HealthTech Accelerator
In 2014, he launched his six-month twice-yearly HealthTech Accelerator with over 225 alumni companies, focusing on digital health and medical device startups. The spring cohort will explore solutions in the areas of maternal medicine, mental health, diagnostics, patient experience, and artificial intelligence.
Devin Dunn, director of Accelerator for Healthtech at TMCi, said in a press release: “Our customized program maximizes the participant experience while identifying the best match between these companies and the Texas Medical Center network.”
This cohort was selected after his November boot camp to introduce potential startups and his members to TMC and Houston’s healthcare community.
The following companies will participate in TMC this month.
Based in Roseville, Minneapolis, Bloom Standard is deploying the primary self-riding pediatric ultrasound to in advance diagnose coronary heart and lung situations in number-one care, far-off and under-resourced settings.
San Francisco-primarily based Ejenta automates far-off tracking and care the use of AI era completely certified by NASA. “Intelligent agents” study from linked devices, claims, and EMR statistics to display sufferers, expect fitness, and offer automatic assistance for sufferers and automatic workflow for clinicians.
Kintsugi, primarily based totally in Berkley, California, is on a project to peer intellectual fitness with greater honestly with the aid of using growing novel voice biomarker infrastructure to come across symptoms and symptoms of despair and tension from brief clips of free-shape speech.
San Francisco-primarily based Lana Health is modernizing affected person experiences, throughout the care continuum with an end-to-end, scalable platform, permitting frictionless care transitions, excessive affected person satisfaction, and higher medical outcomes.
Liberate Medical of Crestwood, Kentucky is improving outcomes for ventilated patients with its breakthrough VentFree non-invasive respiratory muscle protection neurostimulator.
Headquartered in Palo Alto, Limbix is committed to improving mental health with accessible technology.
Nua Surgical Nua Surgical, based in Galway, Ireland, is an award-winning Irish start-up committed to innovation in women’s healthcare.
Houston-based Prana Thoracic develops solutions for early-stage lung cancer detection and intervention.
